Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Xiaosheng Wang

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-7199-7093; OpenAlex author ID A5017283709.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 2)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Pathway Enrichment-Based Unsupervised Learning Identifies Novel Subtypes of Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1007/s12539-025-00705-7↗
  2. Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-sup… Last author DOI 10.1007/s00432-017-2558-4↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Hongjing Ai · 1 shared paper, 2025
  2. Nalin C. W. Goonesekere · 1 shared paper, 2018

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.